Leal Health

About:

Leal is the leading AI-powered treatment decision support platform that democratizes patient access to cancer treatments

Website: https://www.leal.health

Twitter/X: TJectory

Top Investors: Insight Partners, Connecticut Innovations, Contour Venture Partners, TIA Ventures, Amplifyher Ventures

Description:

Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to execute patient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn.

Total Funding Amount:

$27.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-12-01

Contact Email:

tzvia(AT)leal.health

Founders:

Avital Gaziel, Noam Geva, Tzvia Bader

Number of Employees:

11-50

Last Funding Date:

2022-02-07

IPO Status:

Private

© 2024 MyAiNote.com